Author:
Madariaga Ainhoa,Mitchell Sandra A.,Pittman Tyler,Wang Lisa,Bowering Valerie,Kavak Nisan,Quintos Judy,Chang Karen,Ramsahai Janelle,Karakasis Katherine,Welch Stephen A.,Dhani Neesha C.,Lheureux Stephanie,Oza Amit M.
Funder
AstraZeneca
Princess Margaret Cancer Foundation
U.S. Department of Defense
National Cancer Institute
Subject
Obstetrics and Gynecology,Oncology
Reference14 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018
2. New approaches for targeting platinum-resistant ovarian cancer;McMullen;Semin. Cancer Biol.,2021
3. Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial;Lheureux;Lancet,2021
4. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. Bethesda, MD,: US Department of Health and Human Services;National Cancer Institute,2017
5. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine Cancer treatment;Basch;Jama,2017
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献